Opus Genetics (IRD) Interest Coverage Ratio Growth (5y) (2016 - 2025)
Opus Genetics (IRD) Interest Coverage Ratio Growth (5y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Opus Genetics | 3.27 Mn | -56.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -180.86% |
| Sep 30, 2025 | -355.81% |
| Jun 30, 2022 | -576.50% |
| Mar 31, 2022 | -590.08% |
| Dec 31, 2021 | -75.14% |
| Dec 31, 2020 | 59.46% |
| Sep 30, 2020 | 18.42% |
| Jun 30, 2020 | 26.26% |
| Mar 31, 2020 | 13.02% |
| Dec 31, 2019 | 15.12% |
| Sep 30, 2019 | 11.93% |
| Jun 30, 2019 | 9.57% |
| Mar 31, 2019 | 0.38% |
| Dec 31, 2018 | -13.44% |
| Sep 30, 2018 | -11.88% |
| Jun 30, 2018 | -12.38% |
| Mar 31, 2018 | -16.30% |
| Dec 31, 2017 | -14.73% |
| Sep 30, 2017 | -3.72% |
| Jun 30, 2017 | -26.09% |